27 August 2015 - CADTH has received notice of a pending submission from GIlead for elvitegravir with cobicistat and emtricitabine and tenofovir alafenamide for patients with HIV infection.  For information about the patient input process or for additional instructions, please see the patient input page of the CADTH website.

For more details, go to: https://www.cadth.ca/elvitegravircobicistatemtricitabinetenofovir-alafenamide